Shows L-DOPA improves retinal function in diabetic mice, indicating protective mechanisms.
Purpose: Although previous work has shown a post-treatment protective effect of levodopa (L-DOPA) on retinal function in early-stage diabetic retinopathy (DR) in humans, its underlying biology is unknown. This study investigated L-DOPA's post-treatment functional protection with transcriptional changes in the diabetic murine retina. Methods: Assessing retinal and visual function with electroretinography (ERG) and optomotor response (OMR), functional deficits were confirmed in streptozotocin (STZ)-induced diabetic mice. Control and diabetic mice were then treated with continuous L-DOPA/carbidopa (four weeks), L-DOPA/carbidopa (two weeks) followed by washout (two weeks), or vehicle (four weeks). Functional assessments were repeated during the final two weeks, alongside assessment of flicker-evoked retinal vasodilation. After bulk RNA sequencing of retinal tissue, differential gene expression analysis alongside weighted gene co-expression network analysis were performed to determine disease- and treatment-sensitive changes in retinal gene co-expression that correlated with functional protection. Results: After L-DOPA treatment in diabetic mice, ERG oscillatory potential timing and OMR performance were protected for at least two weeks past treatment end. Flicker-induced venule vasodilation also maintained post-treatment improvement, with protective trends in arteriole vasodilation. Differentially expressed genes were comparable between diabetic mice experiencing L-DOPA washout versus continued L-DOPA treatment. Gene co-expression network analysis identified distinct modules across L-DOPA-treated diabetic mice associated with synaptic function and cytoskeletal organization that correlated with functional protection. Conclusions: These findings demonstrate that L-DOPA restores retinal neurovascular function with post-treatment effects in early DR and links this protection to transcriptional programs supporting synapse activity and structural integrity.
No takes yet. Share an insight, caveat, or question.
Chlan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: